The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Melanocortin-4 receptor mutations are a frequent and heterogeneous cause of morbid obesity
Open accessAbstract
By integrating an agonist satiety signal, provided by alpha-melanocyte-stimulating hormone (alpha-MSH), and an antagonist signal, provided by agouti-related protein (AGRP), the melanocortin-4 receptor (MC4-R) is a key element in the hypothalamic control of food intake. Inactivation of the gene encoding this G protein-coupled receptor causes obesity in mice. In humans, frameshift mutations in MC4-R cause an early-onset dominant form of obesity in two families. In this study we find a high frequency (4%) of rare heterozygous MC4-R mutations in a large population of morbidly obese patients. No such mutations were found in controls. By analyzing the phenotypes of the probands carrying these mutations, we demonstrate that these patients display a common, nonsyndromic form of obesity. Interestingly, functional analysis of the mutant receptors indicates that obesity-associated defects in MC4-R range from loss of function to constitutive activation. Transmission of these mutations in the families of the carriers indicates a variable expressivity that is not related to the functional severity of the mutations. This variable expressivity of MC4-R-associated obesity is not due to variations in genes for alpha-MSH or AGRP. Taken together, these results demonstrate that MC4-R mutations are a frequent but heterogeneous genetic cause of morbid obesity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Disruption of POMC-MC4R signalling causes hyperphagia and is the most common known genetic cause of morbid obesity in children193,194.”
From Obesity, kidney dysfunction and hypertension: mechanistic links (2019) · cites this paper as [194]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2000) · PubMed · Cited by 13,173
Obesity : Preventing and managing the global epidemic
Akram, D. S., Astrup, A. V., Atinmo, T., Boissin, J.-L., Bray, G. A., Carroll, K. N., Chitson, P., Chen, C., Dietz, W. H., Hill, J. O., et al. (2000) · Research at the University of Copenhagen (University of Copenhagen) · Cited by 12,945
The Disease Burden Associated With Overweight and Obesity
Must, A. (1999) · JAMA · doi:10.1001/jama.282.16.1523 · Cited by 4,827
The three-factor eating questionnaire to measure dietary restraint, disinhibition and hunger
Stunkard, A. J., & Messick, S. (1985) · Journal of Psychosomatic Research · doi:10.1016/0022-3999(85)90010-8 · Cited by 4,687
A short questionnaire for the measurement of habitual physical activity in epidemiological studies
Baecke, J. A. H., BUREMA, J., & Frijters, J. E. R. (1982) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/36.5.936 · Cited by 3,950
Targeted disruption of the melanocortin-4 receptor results in obesity in mice
Huszar, D., Lynch, C. A., Fairchild-Huntress, V., Dunmore, J. H., Fang, Q., Berkemeier, L. R., Gu, W., Kesterson, R. A., Boston, B. A., Cone, R. D., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)81865-6 · Cited by 3,030
Congenital leptin deficiency is associated with severe early-onset obesity in humans
Montague, C. T., Farooqi, I. S., Whitehead, J. P., Soos, M. A., Rau, H., Wareham, N. J., Sewter, C. P., Digby, J. E., Mohammed, S. N., Hurst, J. A., et al. (1997) · Nature · doi:10.1038/43185 · Cited by 2,936
The Spread of the Obesity Epidemic in the United States, 1991-1998
Mokdad, A. H. (1999) · JAMA · doi:10.1001/jama.282.16.1519 · Cited by 2,384
A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction
Clément, K., Vaisse, C., Lahlou, N., Cabrol, S., Pelloux, V., Cassuto, D., Gourmelen, M., Dina, C., Chambaz, J., Lacorte, J.-M., et al. (1998) · Nature · doi:10.1038/32911 · Cited by 2,346
Self-citationEnvironmental Contributions to the Obesity Epidemic
Hill, J. O., & Peters, J. C. (1998) · Science · doi:10.1126/science.280.5368.1371 · Cited by 2,258
Flagged first, then by citations
Research works printed but not linked: 1
- Rolland-Cachera, 1991, Eur J Clin Nutr, 45, 13
Cited by
Sorted by citations
Items 101–200 of 901
Unraveling the Genetics of Human Obesity
Mutch, D. M., & Clément, K. (2006) · PLoS Genetics · doi:10.1371/journal.pgen.0020188 · Cited by 169
Self-citationPlasma metabolomic profiles enhance precision medicine for volunteers of normal health
Guo, L., Milburn, M. V., Ryals, J. A., Lonergan, S. C., Mitchell, M. W., Wulff, J. E., Alexander, D. C., Evans, A. M., Bridgewater, B., Miller, L. A. D., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1508425112 · Cited by 176
Monogenic Human Obesity Syndromes
Farooqi, I. S. (2004) · Recent Progress in Hormone Research · doi:10.1210/rp.59.1.409 · Cited by 170
Melanocortin 4 Receptor–Deficient Mice as a Novel Mouse Model of Nonalcoholic Steatohepatitis
Itoh, M., Suganami, T., Nakagawa, N., Tanaka, M., Yamamoto, Y., Kamei, Y., Terai, S., Sakaida, I., & Ogawa, Y. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.07.014 · Cited by 170
Biebermann, H., Krude, H., Elsner, A., Chubanov, V., Gudermann, T. W., & Grüters, A. (2003) · Diabetes · doi:10.2337/diabetes.52.12.2984 · Cited by 166
Genetic variant effects on gene expression in human pancreatic islets and their implications for T2D
Viñuela, A., Varshney, A., van de Bunt, M., Prasad, R. B., Asplund, O., Bennett, A., Boehnke, M., Brown, A. A., Erdos, M. R., Fadista, J., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-18581-8 · Cited by 152
Melanocortin-4 Receptor in Energy Homeostasis and Obesity Pathogenesis
Hinney, A., Volckmar, A., & Knoll, N. (2013) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-386933-3.00005-4 · Cited by 162
Schaffer, J. V., & Bolognia, J. L. (2001) · Archives of Dermatology · doi:10.1001/archderm.137.11.1477 · Cited by 155
Flores-Dorantes, M. T., Díaz‐López, Y. E., & Gutiérrez‐Aguilar, R. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00863 · Cited by 170
Iepsen, E. W., Zhang, J., Thomsen, H. S., Hansen, E. L., Hollensted, M., Madsbad, S., Hansen, T., Holst, J. J., Holm, J.-C., & Torekov, S. S. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.05.008 · Cited by 156
Martinelli, C. E., Keogh, J. M., Greenfield, J. R., Henning, E., van der Klaauw, A. A., Blackwood, A., O'Rahilly, S., Roelfsema, F., Camacho-Hübner, C., Pijl, H., et al. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-1369 · Cited by 153
Tao, Y. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2006.02.008 · Cited by 151
Developments in Obesity Genetics in the Era of Genome-Wide Association Studies
Day, F. R., & Loos, R. J. F. (2011) · Lifestyle Genomics · doi:10.1159/000332158 · Cited by 151
Pharmacological Therapy of Obesity: Past, Present, and Future
Weigle, D. S. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030151 · Cited by 148
Young, E. H., Wareham, N. J., Farooqi, I. S., Hinney, A., Hebebrand, J., Scherag, A., O’Rahilly, S., Barroso, I., & Sandhu, M. S. (2007) · International Journal of Obesity · doi:10.1038/sj.ijo.0803609 · Cited by 147
Xiang, Z., Litherland, S. A., Sorensen, N. B., Proneth, B., Wood, M. S., Shaw, A. M., Millard, W. J., & Haskell‐Luevano, C. (2006) · Biochemistry · doi:10.1021/bi0600300 · Cited by 146
Ethnic and population differences in the genetic predisposition to human obesity
Stryjecki, C., Alyass, A., & Meyre, D. (2017) · Obesity Reviews · doi:10.1111/obr.12604 · Cited by 147
Adipose tissue hyperplasia and hypertrophy in common and syndromic obesity-the case of BBS obesity
Horwitz, A., & Birk, R. (2023) · Nutrients · doi:10.3390/nu15153445 · Cited by 143
Emerging Therapeutic Strategies for Obesity
Foster‐Schubert, K. E., & Cummings, D. E. (2006) · Endocrine Reviews · doi:10.1210/er.2006-0041 · Cited by 140
“The role of melanocortins in body weight regulation: opportunities for the treatment of obesity”
MacNeil, D. J., Howard, A. D., Guan, X.-M., Fong, T. M., Nargund, R. P., Bednarek, M. A., Goulet, M. T., Weinberg, D. H., Strack, A. M., Marsh, D. J., et al. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)01989-1 · Cited by 137
Shinyama, H., Masuzaki, H., Fang, H., & Flier, J. S. (2003) · Endocrinology · doi:10.1210/en.2002-220931 · Cited by 136
Genetic approaches to stature, pubertal timing, and other complex traits
Palmert, M. R., & Hirschhorn, J. N. (2003) · Molecular Genetics and Metabolism · doi:10.1016/s1096-7192(03)00107-0 · Cited by 135
van Iersel, L., Brokke, K. E., Adan, R. A. H., Bulthuis, L. C. M., van den Akker, E. L. T., & van Santen, H. M. (2019) · Endocrine Reviews · doi:10.1210/er.2018-00017 · Cited by 146
Loss-of-function mutations in the melanocortin 4 receptor in a UK birth cohort
Wade, K. H., Lam, B. Y. H., Melvin, A., Pan, W., Corbin, L. J., Hughes, D. A., Rainbow, K., Chen, J.-H., Duckett, K., Liu, X., et al. (2021) · Nature Medicine · doi:10.1038/s41591-021-01349-y · Cited by 133
Agouti: from Mouse to Man, from Skin to Fat
Voisey, J., & van Daal, A. (2002) · Pigment Cell Research · doi:10.1034/j.1600-0749.2002.00039.x · Cited by 132
Genetics of common forms of obesity: a brief overview
Lyon, H. N., & Hirschhorn, J. N. (2005) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/82.1.215s · Cited by 135
The Human Obesity Gene Map: The 2000 Update
Përusse, L., Chagnon, Y. C., Weisnagel, S. J., Rankinen, T., Snyder, E. E., Sands, J., & Bouchard, C. (2001) · Obesity Research · doi:10.1038/oby.2001.17 · Cited by 130
Large quantitative effect of melanocortin-4 receptor gene mutations on body mass index
Dempfle, A., Hinney, A., Heinzel-Gutenbrunner, M., Raab, M., Geller, F., Gudermann, T., Schäfer, H., & Hebebrand, J. (2004) · Journal of Medical Genetics · doi:10.1136/jmg.2004.018614 · Cited by 132
Nutrigenomics: The Impact of Biomics Technology on Nutrition Research
Corthesy-Theulaz, I. E., den Dunnen, J. T., Ferré, P., Geurts, J. M. W., Müller, M. M., van Belzen, N., & van Ommen, B. (2005) · Annals of Nutrition and Metabolism · doi:10.1159/000088315 · Cited by 130
Novel Noninvasive Approaches to the Treatment of Obesity: From Pharmacotherapy to Gene Therapy
Angelidi, A. M., Belanger, M. J., Kokkinos, A. D., Koliaki, C. C., & Mantzoros, C. S. (2021) · Endocrine Reviews · doi:10.1210/endrev/bnab034 · Cited by 141
Neural melanocortin receptors in obesity and related metabolic disorders
Girardet, C., & Butler, A. A. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.05.004 · Cited by 128
Calton, M. A., Ersoy, B. A., Zhang, S., Kane, J. P., Malloy, M. J., Pullinger, C. R., Bromberg, Y., Pennacchio, L. A., Dent, R., McPherson, R., et al. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn431 · Cited by 125
Self-citationAppetite Regulation: An Overview
Dhillo, W. S. (2007) · Thyroid · doi:10.1089/thy.2007.0018 · Cited by 127
Melanocortin ligands: 30 years of structure–activity relationship (SAR) studies
Holder, J. R., & Haskell‐Luevano, C. (2004) · Medicinal Research Reviews · doi:10.1002/med.10064 · Cited by 122
In vivo characterization of high Basal signaling from the ghrelin receptor
Petersen, P. S., Woldbye, D. P. D., Madsen, A. N., Egerod, K. L., Jin, C., Lang, M., Rasmussen, M., Beck-Sickinger, A. G., & Holst, B. (2009) · Endocrinology · doi:10.1210/en.2008-1638 · Cited by 121
Genetic Determinants of Childhood Obesity
Littleton, S. H., Berkowitz, R. I., & Grant, S. F. A. (2020) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-020-00496-1 · Cited by 144
Melanocortin-4 receptor gene and physical activity in the Québec Family Study
Loos, R. J. F., Rankinen, T., Tremblay, A., Përusse, L., Chagnon, Y. C., & Bouchard, C. (2004) · International Journal of Obesity · doi:10.1038/sj.ijo.0802869 · Cited by 119
Molecular Genetics of Human Obesity‐Associated MC4R Mutations
Lubrano-Berthelier, C., Cavazos, M. M., Dubern, B., Shapiro, A., Stunff, C. L., Zhang, S., Picart, F., Govaerts, C., Froguel, P., Bougneres, P. F., et al. (2003) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2003.tb03161.x · Cited by 119
Self-citationJacobson, P., Ukkola, O. H., Rankinen, T., Snyder, E. E., Leon, A. S., Rao, D. C., Skinner, J. S., Wilmore, J. H., Lönn, L., Cowan, G. S. M., et al. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020568 · Cited by 119
Goldstone, A. P., Unmehopa, U. A., Bloom, S. R., & Swaab, D. F. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.2.8230 · Cited by 117
Obesity therapy: altering the energy intake-and-expenditure balance sheet
Crowley, V., Yeo, G. S. H., & O’Rahilly, S. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd770 · Cited by 116
Saeed, S., Bonnefond, A., Manzoor, J., Shabir, F., Ayesha, H., Philippe, J., Durand, E., Crouch, H. K., Sand, O., Ali, M. A., et al. (2015) · Obesity · doi:10.1002/oby.21142 · Cited by 125
Self-citationPoor Cell Surface Expression of Human Melanocortin-4 Receptor Mutations Associated with Obesity
Nijenhuis, W. A. J., Garner, K. M., van Rozen, R. J., & Adan, R. A. H. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211326200 · Cited by 115
Heid, I. M., Vollmert, C., Hinney, A., Döring, A., Geller, F., Löwel, H., Wichmann, H. ‐., Illig, T., Hebebrand, J., & Kronenberg, F. (2005) · Journal of Medical Genetics · doi:10.1136/jmg.2004.027011 · Cited by 114
A novel homozygous missense mutation of the leptin gene (N103K) in an obese Egyptian patient
Mazen, I., Gammal, M. E., Abdel‐Hamid, M. S., & Amr, K. S. (2009) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2009.04.002 · Cited by 113
Nahon, J. (2006) · Comptes Rendus Biologies · doi:10.1016/j.crvi.2006.03.021 · Cited by 117
Hypothalamic Melanocortin Receptors and Chronic Regulation of Arterial Pressure and Renal Function
Kuo, J. J., Silva, A. A., & Hall, J. E. (2003) · Hypertension · doi:10.1161/01.hyp.0000048194.97428.1a · Cited by 113
Hebebrand, J., Volckmar, A., Knoll, N., & Hinney, A. (2010) · Obesity Facts · doi:10.1159/000321537 · Cited by 117
Kong, W. M., Stanley, S. A., Gardiner, J., Abbott, C. R., Murphy, K. G., Seth, A., Connoley, I. P., Ghatei, M. A., Stephens, D. A., & Bloom, S. R. (2003) · The FASEB Journal · doi:10.1096/fj.02-0805fje · Cited by 113
Functions for pro-opiomelanocortin-derived peptides in obesity and diabetes
Mountjoy, K. G. (2010) · Biochemical Journal · doi:10.1042/bj20091957 · Cited by 110
Relevance of animal models to human eating disorders and obesity
Casper, R. C., Sullivan, E. L., & Tecott, L. H. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1102-2 · Cited by 111
del Giudice, E. M., Cirillo, G., Nigro, V., Santoro, N., D'Urso, L., Raimondo, P., Cozzolino, D., Scafato, D., & Perrone, L. (2002) · International Journal of Obesity · doi:10.1038/sj.ijo.0801983 · Cited by 108
Structures of active melanocortin-4 receptor–Gs-protein complexes with NDP-α-MSH and setmelanotide
Heyder, N., Kleinau, G., Speck, D., Schmidt, A., Paisdzior, S., Szczepek, M., Bauer, B., Koch, A., Gallandi, M., Kwiatkowski, D., et al. (2021) · Cell Research · doi:10.1038/s41422-021-00569-8 · Cited by 110
New perspectives regarding β2‐adrenoceptor ligands in the treatment of asthma
Walker, J. K. L., Penn, R., Hanania, N. A., Dickey, B. F., & Bond, R. A. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.01178.x · Cited by 105
Resequencing Genomic DNA of Patients With Severe Hypertriglyceridemia (MIM 144650)
Wang, J., Cao, H., Ban, M. R., Kennedy, B. A., Zhu, S., Anand, S. S., Yusuf, S., Pollex, R. L., & Hegele, R. A. (2007) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.107.150680 · Cited by 108
Metal Ion-mediated Agonism and Agonist Enhancement in Melanocortin MC1 and MC4 Receptors
Holst, B., Elling, C., & Schwartz, T. W. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202103200 · Cited by 104
Melanocortin signaling in the CNS directly regulates circulating cholesterol
Pérez–Tilve, D., Hofmann, S. M., Basford, J. E., Nogueiras, R., Pfluger, P. T., Patterson, J. T., Grant, E., Wilson, H., Granholm, N. A., Arnold, M., et al. (2010) · Nature Neuroscience · doi:10.1038/nn.2569 · Cited by 103
Potoczna, N., Branson, R., Kral, J. G., Piec, G., Steffen, R., Ricklin, T. P., Hoehe, M. R., Lentes, K., & Horber, F. (2004) · Journal of Gastrointestinal Surgery · doi:10.1016/j.gassur.2004.09.032 · Cited by 103
Albarado, D. C., McClaine, J. W., Stephens, J. M., Mynatt, R. L., Ye, J., Bannon, A. W., Richards, W. G., & Butler, A. A. (2003) · Endocrinology · doi:10.1210/en.2003-0452 · Cited by 103
Obesity-associated mutations in the melanocortin 4 receptor provide novel insights into its function
Govaerts, C., Srinivasan, S., Shapiro, A., Zhang, S., Picard, F., Clément, K., Lubrano-Berthelier, C., & Vaisse, C. (2005) · Peptides · doi:10.1016/j.peptides.2004.11.042 · Cited by 103
Self-citationKobayashi, H., Ogawa, Y., Shintani, M., Ebihara, K., Shimodahira, M., Iwakura, T., Hino, M., Ishihara, T., Ikekubo, K., Kurahachi, H., et al. (2002) · Diabetes · doi:10.2337/diabetes.51.1.243 · Cited by 103
Hirschhorn, J. N., & Gajdos, Z. K. Z. (2010) · Annual Review of Medicine · doi:10.1146/annurev.med.091708.162036 · Cited by 105
Primary Cilia as Signaling Hubs in Health and Disease
Nishimura, Y., Kasahara, K., Shiromizu, T., Watanabe, M., & Inagaki, M. (2018) · Advanced Science · doi:10.1002/advs.201801138 · Cited by 105
Tao, Y., & Segaloff, D. L. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0519 · Cited by 102
Farooqi, I. S. (2008) · KARGER eBooks · doi:10.1159/000115333 · Cited by 101
Chapter 6 Mutations in Melanocortin‐4 Receptor and Human Obesity
Tao, Y. (2009) · Progress in molecular biology and translational science · doi:10.1016/s1877-1173(09)88006-x · Cited by 102
Genetics and the Pathophysiology of Obesity
Clément, K., & Ferré, P. (2003) · Pediatric Research · doi:10.1203/01.pdr.0000059753.61905.58 · Cited by 101
Holder, J. R., Bauzo, R. M., Xiang, Z., & Haskell‐Luevano, C. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm0104872 · Cited by 99
Integrating Hunger with Rival Motivations
Hickey, A. K. S., & Krashes, M. J. (2020) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2020.04.006 · Cited by 96
Association of feather colour with constitutively active melanocortin 1 receptors in chicken
Ling, M. K., Lagerström, M. C., Fredriksson, R., Okimoto, R., Mundy, N. I., Takeuchi, S., & Schiöth, H. B. (2003) · European Journal of Biochemistry · doi:10.1046/j.1432-1033.2003.03506.x · Cited by 97
Houston, R. D., Cameron, N. D., & Rance, K. A. (2004) · Animal Genetics · doi:10.1111/j.1365-2052.2004.01182.x · Cited by 97
The Role of the Agouti-Related Protein in Energy Balance Regulation
Ilnytska, O., & Argyropoulos, G. A. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-8104-4 · Cited by 97
Fairbrother, U. L., Kidd, E., Malagamuwa, T., & Walley, A. J. (2018) · Current Diabetes Reports · doi:10.1007/s11892-018-1053-x · Cited by 104
Binge-eating episodes are not characteristic of carriers of melanocortin-4 receptor gene mutations
Hebebrand, J., Geller, F., Dempfle, A., Heinzel‐Gutenbrunner, M., Raab, M. S., Gerber, G., Wermter, A. ‐., Horro, F. F., Blundell, J. E., Schäfer, H., et al. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001491 · Cited by 96
The Role of Melanocortin 3 Receptor Gene in Childhood Obesity
Lee, Y. S., Poh, L. K. S., Kek, B. L. K., & Loke, K. Y. (2007) · Diabetes · doi:10.2337/db07-0225 · Cited by 95
Mercer, J. G., & Speakman, J. R. (2001) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(00)00053-1 · Cited by 94
The G protein-coupled receptors: Pharmacogenetics and Disease
Thompson, M. D., Burnham, W. M., & Cole, D. E. C. (2005) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408360591001895 · Cited by 93
Mul, J. D., van Boxtel, R., Bergen, D. J. M., Brans, M. A. D., Brakkee, J. H., Toonen, P. W., Garner, K. M., Adan, R. A. H., & Cuppen, E. P. J. G. (2011) · Obesity · doi:10.1038/oby.2011.81 · Cited by 93
Wang, Y., Bernard, A., Comblain, F., Yue, X., Paillart, C., Zhang, S., Reiter, J. F., & Vaisse, C. (2021) · Journal of Clinical Investigation · doi:10.1172/jci142064 · Cited by 100
Self-citationA Homozygous Null Mutation Delineates the Role of the Melanocortin-4 Receptor in Humans
Lubrano-Berthelier, C., Stunff, C. L., Bougneres, P. F., & Vaisse, C. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031993 · Cited by 92
Self-citationMorgan, D. A., McDaniel, L. N., Yin, T. C., Khan, M. Z., Jiang, J., Acevedo, M. R., Walsh, S. A., Ponto, L. L. B., Norris, A. W., Lutter, M. L., et al. (2015) · Diabetes · doi:10.2337/db14-1257 · Cited by 92
Rodent Models of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis
Imajo, K., Yoneda, M., Kessoku, T., Ogawa, Y., Maeda, S., Sumida, Y., Hyogo, H., Eguchi, Y., Wada, K., & Nakajima, A. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms141121833 · Cited by 93
Ahn, J. D., Dubern, B., Lubrano-Berthelier, C., Clément, K., & Karsenty, G. (2006) · Endocrinology · doi:10.1210/en.2006-0281 · Cited by 90
Activation of MAP kinase by MC4-R through PI3 kinase
Vongs, A., Lynn, N. M., & Rosenblum, C. I. (2004) · Regulatory Peptides · doi:10.1016/j.regpep.2004.02.018 · Cited by 89
Hainerová, I. A., Larsen, L. H., Holst, B., Finková, M., Hainer, V., Lebl, J., Hansen, T. F., & Pedersen, O. B. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0352 · Cited by 88
Eating disorders: the current status of molecular genetic research
Scherag, S., Hebebrand, J., & Hinney, A. (2009) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-009-0085-9 · Cited by 88
The genetic epidemiology of melanocortin 4 receptor variants
Loos, R. J. F. (2011) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2011.01.033 · Cited by 89
Chai, B., Li, J.-Y., Zhang, W., Newman, E. A., Ammori, J. B., & Mulholland, M. W. (2006) · Peptides · doi:10.1016/j.peptides.2006.05.005 · Cited by 87
Manco, M., & Dallapiccola, B. (2012) · PEDIATRICS · doi:10.1542/peds.2011-2717 · Cited by 91
Oswal, A., & Yeo, G. S. H. (2007) · Obesity Reviews · doi:10.1111/j.1467-789x.2007.00378.x · Cited by 87
Diurnal Rhythm of Agouti-Related Protein and Its Relation to Corticosterone and Food Intake
Lu, X., Shieh, K.-R., Kabbaj, M., Barsh, G. S., Akil, H., & Watson, S. J. (2002) · Endocrinology · doi:10.1210/en.2002-220150 · Cited by 87
Pharmacological Characterization of Human Incretin Receptor Missense Variants
Fortin, J., Schroeder, J. C., Zhu, Y., Beinborn, M., & Kopin, A. S. (2009) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.160531 · Cited by 88
The prevalence of folate-remedial MTHFR enzyme variants in humans
Marini, N. J., Gin, J., Ziegle, J. S., Keho, K. H., Ginzinger, D. G., Gilbert, D. A., & Rine, J. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0802813105 · Cited by 88
Mechanisms of Disease: the genetic basis of coronary heart disease
Kullo, I. J., & Ding, K. (2007) · Nature Clinical Practice Cardiovascular Medicine · doi:10.1038/ncpcardio0982 · Cited by 86
Fu, L., & van den Pol, A. N. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.0749-08.2008 · Cited by 92
Kelleher, C. M., Silverman, E. K., Broekelmann, T. J., Litonjua, A. A., Hernandez, M., Sylvia, J. S., Stoler, J. M., Reilly, J. J., Chapman, H. A., Speizer, F. E., et al. (2005) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2005-0206oc · Cited by 86
Making sense of the sensory regulation of hunger neurons
Chen, Y., & Knight, Z. A. (2016) · BioEssays · doi:10.1002/bies.201500167 · Cited by 88
Pituitary abnormalities in Prader–Willi syndrome and early onset morbid obesity
Miller, J. L., Goldstone, A. P., Couch, J. A., Shuster, J. J., He, G., Driscoll, D. J., Liu, Y., & Schmalfuss, I. M. (2007) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.31677 · Cited by 82
Multiple melanocortin receptors are expressed in bone cells
Zhong, Q., Sridhar, S., Ruan, L., Ding, K., XIE, D., Insogna, K. L., Kang, B., XU, J., Bollag, R. J., & Isales, C. M. (2005) · Bone · doi:10.1016/j.bone.2005.01.020 · Cited by 82
A common polymorphism in the interleukin-6 gene promoter is associated with overweight
Asterholm, I. W., Eriksson, A.-L., Berndtsson, A., Hoffstedt, J., Skrtic, S., Hedner, T., Hultén, L. M., Wiklund, O., Ohlsson, C., & Jansson, J.-O. (2004) · International Journal of Obesity · doi:10.1038/sj.ijo.0802763 · Cited by 81
Metadata
- Authors
- Vaisse, C., Clement, K., Durand, E., Hercberg, S., Guy-Grand, B., & Froguel, P.
- Affiliations
- Centre National de la Recherche Scientifique (FR)
- Hôtel-Dieu de Paris (FR)
- University of California, San Francisco (US)
- Corresponding author
- Vaisse, Christian
- Venue
- Journal of Clinical Investigation
- Published
- 2000-07-15
- Volume
- 106
- Issue
- 2
- Pages
- 253-262
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC314306
- OpenAlex
- W2118192748
- Cited by
- 897
- References
- 40
- Citations by year
- 2026: 11 · 2025: 17 · 2024: 21 · 2023: 26 · 2022: 18 · 2021: 32 · 2020: 27 · 2019: 28 · 2018: 27 · 2017: 22 · 2016: 26 · 2015: 34 · 2014: 36 · 2013: 22 · 2012: 28
- FWCI
- 20.59
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Danone
- Instituto Danone
- Servier
- Topics
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
- Health Sciences › Medicine › Reproductive Medicine › Hypothalamic control of reproductive hormones
- Social Sciences › Psychology › Clinical Psychology › Eating Disorders and Behaviors
- Keywords
- melanocortin-4 receptor, MC4R mutations, morbid obesity, agouti-related protein, alpha-melanocyte-stimulating hormone, G protein-coupled receptors, loss of function, constitutive receptor activation, variable expressivity, genetic heterogeneity
- MeSH terms
- Adolescent, Adult, Aged, Aged, 80 and over, alpha-MSH, Child, Eating, Female, Genetic Testing, Heterozygote, Humans, Male, Middle Aged, Mutation, Obesity, Morbid, Pedigree, Proteins, Cohort Studies, Frameshift Mutation, Receptors, Corticotropin, Penetrance, Mutation, Missense, Intercellular Signaling Peptides and Proteins, Receptor, Melanocortin, Type 4, Agouti-Related Protein
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review